Using the Scaffold of FDA-Approved Drugs with Trypanocidal Activity to Identify New Anti- Trypanosoma cruzi Agents: An In Silico and In Vitro Approach.
Saved in:
| Title: | Using the Scaffold of FDA-Approved Drugs with Trypanocidal Activity to Identify New Anti- Trypanosoma cruzi Agents: An In Silico and In Vitro Approach. |
|---|---|
| Authors: | Vázquez-Jiménez, Lenci K.1,2 (AUTHOR), González-González, Alonzo1,2 (AUTHOR), Delgado-Maldonado, Timoteo1,2,3 (AUTHOR), Gómez-Escobedo, Rogelio3,4 (AUTHOR), Avalos-Navarro, Guadalupe4,5 (AUTHOR), Moreno-Rodríguez, Adriana1,5 (AUTHOR), Paz-González, Alma D.1,2 (AUTHOR), Ortiz-Pérez, Eyra1,3 (AUTHOR), Nogueda-Torres, Benjamín3,4 (AUTHOR), Rivera, Gildardo1,5 (AUTHOR) giriveras@ipn.mx |
| Source: | Molecules. Apr2026, Vol. 31 Issue 8, p1327. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14203049 |
|---|---|
| DOI: | 10.3390/molecules31081327 |
